Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 800

1.

Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.

Zhang H, Chen W, Duan CJ, Zhang CF.

World J Surg Oncol. 2013 Jun 18;11:141. doi: 10.1186/1477-7819-11-141.

2.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0.

PMID:
20108042
3.

Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5.

PMID:
19526206
4.

Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.

Zhang H, Duan CJ, Zhang H, Cheng YD, Zhang CF.

Asian Pac J Cancer Prev. 2013;14(5):2851-7.

5.

Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.

Li K, Wang RW, Jiang YG, Zou YB, Guo W.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S459-66. doi: 10.1245/s10434-012-2792-6.

PMID:
23238694
6.

STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?

Akhtar J, Wang Z, Yu C, Zhang ZP, Bi MM.

Ann Surg Oncol. 2014 Jan;21(1):315-21. doi: 10.1245/s10434-013-3215-z.

PMID:
23975322
7.

Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.

Jia Y, Wang N, Wang J, Tian H, Ma W, Wang K, Tan B, Zhang G, Yang S, Bai B, Cheng Y.

Ann Surg Oncol. 2014 Jan;21(1):329-36. doi: 10.1245/s10434-013-3225-x.

PMID:
23982252
8.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066.

PMID:
21882196
9.

Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?

Shi M, Wang Z, Song L, Wang D, Sun Z.

Med Oncol. 2014 May;31(5):951. doi: 10.1007/s12032-014-0951-2.

PMID:
24737010
10.

Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.

Zhang H, Duan CJ, Chen W, Wang SQ, Zhang SK, Dong S, Cheng YD, Zhang CF.

Asian Pac J Cancer Prev. 2012;13(5):2355-62.

11.

Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.

Gao C, Pang L, Ren C, Ma T.

Pathol Oncol Res. 2012 Apr;18(2):471-7. doi: 10.1007/s12253-011-9470-z.

PMID:
22102006
12.

XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.

Shiozaki A, Kosuga T, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K, Iitaka D, Nakashima S, Shimizu H, Ishimoto T, Kitagawa M, Nakou Y, Kishimoto M, Liu M, Otsuji E.

Ann Surg Oncol. 2013 Sep;20(9):3140-50. doi: 10.1245/s10434-012-2474-4.

PMID:
22805860
13.

Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.

Guo W, Zhu T, Dong Z, Cui L, Zhang M, Kuang G.

Clin Exp Metastasis. 2013 Dec;30(8):977-92. doi: 10.1007/s10585-013-9597-2.

PMID:
23793925
14.

High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.

Li Y, Wen ZS, Yang HX, Luo RZ, Zhang Y, Zhang MF, Wang X, Jia WH.

Ann Surg Oncol. 2011 Nov;18(12):3370-6. doi: 10.1245/s10434-011-1725-0.

PMID:
21630125
15.

Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.

Wang Q, Zhu H, Xiao Z, Zhang W, Liu X, Zhang X, He J, Sun K, Wang L, Xu N.

World J Surg Oncol. 2013 Oct 16;11:278. doi: 10.1186/1477-7819-11-278.

16.

SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.

Akagi I, Miyashita M, Makino H, Nomura T, Hagiwara N, Takahashi K, Cho K, Mishima T, Takizawa T, Tajiri T.

Ann Surg Oncol. 2008 Oct;15(10):2965-75. doi: 10.1245/s10434-008-9986-y.

PMID:
18612694
17.

Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.

Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN.

Am J Gastroenterol. 2005 Aug;100(8):1835-43. Erratum in: Am J Gastroenterol. 2006 Sep;101(9):2171.

PMID:
16086722
18.

Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.

Fang WK, Gu W, Liao LD, Chen B, Wu ZY, Wu JY, Shen J, Xu LY, Li EM.

Asian Pac J Cancer Prev. 2014;15(2):871-6.

19.

Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance.

Fu Y, Zhao H, Li XS, Kang HR, Ma JX, Yao FF, Du N.

Tumour Biol. 2014 Nov;35(11):11283-7. doi: 10.1007/s13277-014-2430-y.

PMID:
25117073
20.

The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.

Zhang JY, Bai CY, Bai YQ, Zhang JY, Wu ZY, Wang SH, Xu XE, Wu JY, Zhu Y, Rui Y, Li EM, Xu LY.

Hum Pathol. 2014 Oct;45(10):2014-22. doi: 10.1016/j.humpath.2014.05.014.

PMID:
25090917
Items per page

Supplemental Content

Support Center